160 related articles for article (PubMed ID: 9421412)
1. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells.
Ohtani KI; Shimizu H; Sato N; Mori M
Endocrinology; 1998 Jan; 139(1):172-8. PubMed ID: 9421412
[TBL] [Abstract][Full Text] [Related]
2. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone hydrochloride stimulates insulin secretion in HIT-T 15 cells by inducing Ca2+ influx.
Ohtani K; Shimizu H; Tanaka Y; Sato N; Mori M
J Endocrinol; 1996 Jul; 150(1):107-11. PubMed ID: 8708551
[TBL] [Abstract][Full Text] [Related]
4. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK.
Deng R; Nie A; Jian F; Liu Y; Tang H; Zhang J; Zhang Y; Shao L; Li F; Zhou L; Wang X; Ning G
Biochim Biophys Acta; 2014 Jan; 1840(1):577-85. PubMed ID: 24144566
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.
Inoue Y; Tanigawa K; Nakamura S; Xu G; Kawaguchi M; Kato Y; Tamura K
Diabetes Res Clin Pract; 1995 Jan; 27(1):19-26. PubMed ID: 7781490
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
Zhang B; Saku K; Arakawa K
Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats.
Shimabukuro M; Zhou YT; Lee Y; Unger RH
J Biol Chem; 1998 Feb; 273(6):3547-50. PubMed ID: 9452481
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin inhibits vasopressin-stimulated phosphoinositide hydrolysis and influx of extracellular calcium in clonal hamster beta (HIT) cells.
Richardson SB; Laya T; Gibson M; Eyler N; Van Ooy M
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):847-51. PubMed ID: 1361725
[TBL] [Abstract][Full Text] [Related]
11. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro.
Gralinski MR; Rowse PE; Breider MA
J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of KATP channel activity by troglitazone in CRI-G1 insulin-secreting cells.
Lee K; Ibbotson T; Richardson PJ; Boden PR
Eur J Pharmacol; 1996 Oct; 313(1-2):163-7. PubMed ID: 8905344
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells.
Tsuchiya T; Shimizu H; Shimomura K; Mori M
Am J Nephrol; 2003; 23(4):222-8. PubMed ID: 12840598
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sparing effects of troglitazone in rat pancreatic islets.
Bollheimer LC; Troll S; Landauer H; Wrede CE; Schölmerich J; Buettner R
J Mol Endocrinol; 2003 Aug; 31(1):61-9. PubMed ID: 12914525
[TBL] [Abstract][Full Text] [Related]
15. Effects of high-dose troglitaz one on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits.
Zhang B; Shiomi M; Tanaka H; Mei J; Fan P; Tsujita Y; Horikoshi H; Saku K
Eur J Drug Metab Pharmacokinet; 2001; 26(3):185-92. PubMed ID: 11695719
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.
Satoh H; Tsukamoto K; Hashimoto Y; Hashimoto N; Togo M; Hara M; Maekawa H; Isoo N; Kimura S; Watanabe T
Biochem Biophys Res Commun; 1999 Jan; 254(3):757-63. PubMed ID: 9920814
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
Fujiwara T; Wada M; Fukuda K; Fukami M; Yoshioka S; Yoshioka T; Horikoshi H
Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
[TBL] [Abstract][Full Text] [Related]
20. Glitazones exert multiple effects on β-cell stimulus-secretion coupling.
Düfer M; Noack K; Edalat A; Krippeit-Drews P; Drews G
Mol Pharmacol; 2013 Jan; 83(1):51-60. PubMed ID: 23024191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
